Non-Antibody Products — page 2 of 44,716
Non-Antibody Products
Page 2 of 44,716
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| A-366 | A potent, peptide-competitive inhibitor of the lysine methyltransferase G9… | 10 mg | 16081-10 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| A-366 | A potent, peptide-competitive inhibitor of the lysine methyltransferase G9… | 5 mg | 16081-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-366 | A potent, peptide-competitive inhibitor of the lysine methyltransferase G9… | 50 mg | 16081-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-419259 | An inhibitor of Src family kinases, including Src, LCK, Lyn, and Hck (IC50… | 1 mg | 25605-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-419259 | An inhibitor of Src family kinases, including Src, LCK, Lyn, and Hck (IC50… | 10 mg | 25605-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-419259 | An inhibitor of Src family kinases, including Src, LCK, Lyn, and Hck (IC50… | 5 mg | 25605-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-443654 | A pan Akt inhibitor (Ki = 160 pmol / L for all three isoforms) that interf… | 1 mg | 16499-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-443654 | A pan Akt inhibitor (Ki = 160 pmol / L for all three isoforms) that interf… | 5 mg | 16499-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-443654 | A pan Akt inhibitor (Ki = 160 pmol / L for all three isoforms) that interf… | 500 µg | 16499-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 1 mg | 28279-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 10 mg | 28279-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 25 mg | 28279-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 5 mg | 28279-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 1 mg | 24119-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 10 mg | 24119-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 25 mg | 24119-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 5 mg | 24119-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 1 mg | 17358-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 10 mg | 17358-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 5 mg | 17358-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 1 mg | 17382-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 10 mg | 17382-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 25 mg | 17382-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 5 mg | 17382-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 1 mg | 18715-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 10 mg | 18715-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 5 mg | 18715-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 500 µg | 18715-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 1 mg | 29972-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 10 mg | 29972-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 5 mg | 29972-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 500 µg | 29972-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 1 mg | 21256-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 10 mg | 21256-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 25 mg | 21256-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 5 mg | 21256-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 10 mg | 11900-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 25 mg | 11900-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 5 mg | 11900-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-769662 | A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… | 50 mg | 11900-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-770041 | An orally bioavailable LCK kinase inhibitor (IC50 = 0.147 µM); selec… | 1 mg | 32854-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-770041 | An orally bioavailable LCK kinase inhibitor (IC50 = 0.147 µM); selec… | 5 mg | 32854-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-77-01 | A potent inhibitor of the TGF-β1 receptor ALK5 (IC550 = 25 nM), block… | 1 mg | 18396-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-77-01 | A potent inhibitor of the TGF-β1 receptor ALK5 (IC550 = 25 nM), block… | 10 mg | 18396-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-77-01 | A potent inhibitor of the TGF-β1 receptor ALK5 (IC550 = 25 nM), block… | 25 mg | 18396-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-77-01 | A potent inhibitor of the TGF-β1 receptor ALK5 (IC550 = 25 nM), block… | 5 mg | 18396-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-771726 | An active metabolite of leflunomide; inhibits DHODH (IC50 = 0.23 µM)… | 10 mg | 14404-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-771726 | An active metabolite of leflunomide; inhibits DHODH (IC50 = 0.23 µM)… | 25 mg | 14404-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-771726 | An active metabolite of leflunomide; inhibits DHODH (IC50 = 0.23 µM)… | 5 mg | 14404-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A-784168 | A TRPV1 competitive antagonist; inhibits capsaicin-induced activation of T… | 1 mg | 32855-1 |
CAYMAN CHEMICAL COMPANY |
More Info |